inbrx-109
inbrx-109: 2 clinical trials tracked.
inbrx-109 evidence translation
What we can confirm
2 tracked trials
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about inbrx-109, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (2)
A Randomized, Blinded, Placebo-controlled, Phase 2 Study of INBRX-109 in Unresectable or Metastatic Conventional Chondrosarcoma
Primary endpoint: Progression-free survival per RECISTv1.1 by real time IRR comparing INBRX-109 and placebo
InterventionalRandomizedquadruple206 enrolledStarted 2021-09Completion 2026-1250 sites · Australia, France, Germany, Ireland…Inhibrx Biosciences, Inc
An Open-Label, Multicenter, First-in-Human, Phase 1 Dose-Escalation and Multicohort Expansion Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Primary endpoint: Frequency and severity of adverse events of INBRX-109
Interventionalopen411 targetStarted 2018-10Completion 2029-0637 sites · France, Italy, Netherlands, Spain…Inhibrx Biosciences, Inc